Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
OCUL | OCULAR THERAPEUTIX, INC | Chief Medical Officer | $744K | -$7.59K | -1.01% | Feb 3, 2024 |
ADVM | Adverum Biotechnologies, Inc. | Chief Medical Officer | Aug 2, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|